Islet transplantation has shown great promise as an experimental treatment for Type 1 diabetes, but current clinical protocols have problems with long-term graft survival when islets are transplanted into an inflammatory, immunogenic host environment. Encapsulation strategies designed to present a biocompatible barrier between graft and host may offer solutions to these problems.

This content is only available as a PDF.